Our study has revealed a new remission mechanism whereby effector Tregs migrate into the crescentic glomerulonephritis via the CCL22/17–CCR4 axis that is facilitated by M2‐like type macrophages that are induced by IL‐6R blockade. The gene discussed is CCR4; the disease is crescentic glomerulonephritis.